CAE:TSXCAE Inc. Analysis
Data as of 2026-05-13 - not real-time
CA$35.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading just above its recent support zone, with the short‑term moving average sitting below the mid‑term average, a classic bearish alignment. RSI has slipped below the 50 mark, indicating modest downside pressure, while the MACD line has crossed above its signal, offering a faint bullish hint that has not yet materialized into price strength. Volume has been on a downward trend, and the 30‑day volatility remains elevated, suggesting the price could swing sharply on new information. The beta is modestly above one, pointing to higher sensitivity to market moves, and the maximum historical drawdown exceeds the high‑20% range, underscoring the downside risk. Valuation metrics show a price well above the discounted cash‑flow estimate, making the shares appear overvalued despite a price‑to‑earnings multiple that roughly tracks the industry average. The company carries a high debt load relative to equity and does not pay a dividend, limiting income‑focused appeal.
Fundamental and news backdrop: Recent announcements reveal a strategic overhaul: roughly 2% of the workforce is being cut, non‑core assets such as the Flightscape software unit are being explored for divestiture, and the new CEO is steering the business toward defense‑related opportunities. Analysts anticipate a year‑over‑year earnings decline even as revenue modestly rises, and one broker has trimmed its price target, though the consensus recommendation remains a buy. The market sentiment index reflects “Extreme Greed,” which may be inflating the current price. If the defense pivot gains traction and cost‑saving measures improve cash generation, there could be a meaningful upside, but the combination of high leverage, bearish technicals, and valuation gap sustains a cautious stance.
Fundamental and news backdrop: Recent announcements reveal a strategic overhaul: roughly 2% of the workforce is being cut, non‑core assets such as the Flightscape software unit are being explored for divestiture, and the new CEO is steering the business toward defense‑related opportunities. Analysts anticipate a year‑over‑year earnings decline even as revenue modestly rises, and one broker has trimmed its price target, though the consensus recommendation remains a buy. The market sentiment index reflects “Extreme Greed,” which may be inflating the current price. If the defense pivot gains traction and cost‑saving measures improve cash generation, there could be a meaningful upside, but the combination of high leverage, bearish technicals, and valuation gap sustains a cautious stance.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish moving‑average crossover and price near support
- Earnings decline forecast and decreasing volume
- High short‑term volatility and elevated beta
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Ongoing restructuring and defense‑focused growth strategy
- Cost reductions from workforce cuts and asset divestitures
- Potential upside if cash flow improves despite overvaluation
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Long‑term demand for defense simulation and training solutions
- Strategic refocus on core simulation business
- Opportunity for valuation compression if debt is managed
Key Metrics & Analysis
Financial Health
Revenue Growth2.30%
Profit Margin7.73%
P/E Ratio30.2
ROE7.72%
ROA3.74%
Debt/Equity61.83
P/B Ratio2.2
Op. Cash FlowCA$929.0M
Free Cash FlowCA$484.4M
Industry P/E30.1
Technical Analysis
TrendBearish
RSI44.5
SupportCA$34.12
ResistanceCA$38.66
MA 20CA$35.80
MA 50CA$37.00
MA 200CA$39.26
MACDBullish
VolumeDecreasing
Fear & Greed Index89.41
Valuation
Fair ValueCA$13.46
Target PriceCA$46.86
Upside/Downside31.44%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.14
Volatility25.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.